Antianxiety effect of cannabidiol in the elevated plus-maze

Cited by (378)

Items 201–300 of 378

1. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
   Hugo Bayer, Cristina Aparecida Jark Stern, Fernanda Troyner, Lucas Gazarini, Francisco Silveira Guimarães, Leandro Jose Bertoglio · 2021 · Neuropharmacology
2. Medicinal Cannabis and Central Nervous System Disorders
   Yuma T. Ortiz, Lance Richard McMahon, Jenny L. Wilkerson · 2022 · Frontiers in Pharmacology
3. Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors
   Jaqueline Maisa Franzen, Isabel Werle, Felipe Vanz, Bruno Biscaia de Oliveira, Laura Maria Martins Nascimento, Francisco Silveira Guimarães, Leandro Jose Bertoglio · 2022 · Neuropharmacology
4. Can marijuana make it better? Prospective effects of marijuana and temperament on risk for anxiety and depression.
   Victoria Ann Grunberg, Kismet A. Cordova, L. Cinnamon Bidwell, Tiffany A. Ito · 2015 · Psychology of Addictive Behaviors
5. The Anxiolytic Effects of Cannabidiol (CBD)
   Antônio Waldo Zuardi, José Alexandre S. Crippa, Jaime E. C. Hallak, Alline Cristina Campos, Francisco Silveira Guimarães · 2017 · Elsevier eBooks
6. Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor
   Gomes, Felipe V., Alves, Fernando H.F., Guimarães, Francisco S., Correa, Fernando M.A., Resstel, Leonardo B.M., Crestani, Carlos C. · 2013 · European Neuropsychopharmacology
7. Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice
   Georgia Watt, Rose Chesworth, Magdalena Przybyla, Arne Ittner, Brett Garner, Lars Matthias Ittner, Tim Karl · 2020 · Pharmacology Biochemistry and Behavior
8. Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory
   Joshua S. Kaplan, J. K. Wagner, K. Reid, Finn McGuinness, S. Arvila, M. Brooks, H. Stevenson, J. Jones, B. Risch, T. McGillis et al. · 2021 · Frontiers in Behavioral Neuroscience
9. Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures
   Joshua T. Dearborn, Hemanth R. Nelvagal, Nicholas R. Rensing, Keigo Takahashi, Stephanie M. Hughes, Thomas M. Wishart, Jonathan D. Cooper, Michael L. Wong, Mark S. Sands · 2022 · Scientific Reports
10. Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury
    Marcelo Kwiatkoski, Francisco Silveira Guimarães, Elaine Aparecida Del Bel · 2011 · Neurotoxicity Research
11. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews
    Erin M. Rock, Megan T. Sullivan, Stephen A. Collins, Hannah Goodman, Cheryl L. Limebeer, Raphael Mechoulam, Linda A. Parker · 2020 · Psychopharmacology
12. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
    Michael Bloomfield, Yumeya Yamamori, Chandni Hindocha, A. Jones, Jocelyn LL Yim, Hannah R Walker, Ben K. Statton, Matthew B. Wall, Rachel Lees, Oliver David Howes et al. · 2022 · Psychopharmacology
13. Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
    C. Kwee, Joop van Gerven, Fleur L.P. Bongaerts, Daniëlle C. Cath, Gabriël E. Jacobs, Johanna M.P. Baas, Lucianne Groenink · 2022 · Journal of Psychopharmacology
14. Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?
    Manoela V. Fogaça, Ismael Galve‐Roperh, Francisco Silveira Guimarães, Alline Cristina Campos · 2013 · Current Neuropharmacology
15. Cannabidiol as a potential medicine
    Roger G. Pertwee · 2005 · Birkhäuser-Verlag eBooks
16. Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice
    Aymen H. Sadaka, Ana G. Ozuna, Richard J. Ortiz, Praveen Kulkarni, Clare T. Johnson, Heather B. Bradshaw, Bruce S. Cushing, Ai-Ling Li, Andrea G. Hohmann, Craig F. Ferris · 2021 · Journal of Translational Medicine
17. Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice
    Xiao Han, Xiankui Song, Dake Song, Guanbo Xie, Hongyan Guo, Ning Wu, Jin Li · 2022 · Psychopharmacology
18. Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
    C. Kwee, N.A. Leen, Rian C. Van der Kamp, Caspar J. Van Lissa, Daniëlle C. Cath, Lucianne Groenink, Johanna M.P. Baas · 2023 · European Neuropsychopharmacology
19. Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review
    João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, Alline Cristina Campos, Francisco Silveira Guimarães, Antônio Waldo Zuardi, José Alexandre S. Crippa · 2023 · Cannabis and Cannabinoid Research
20. Anxiolytic-Like Effects of 4- O- Methylhonokiol Isolated from Magnolia officinalis Through Enhancement of GABAergic Transmission and Chloride Influx
    Huishan Han, Jae‐Kyung Jung, Sang‐Bae Han, Sang-Yoon Nam, Ki Wan Oh, Jin Tae Hong · 2011 · Journal of Medicinal Food
21. Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
    João Luís Q. Simei, José Diogo R. Souza, João Francisco Cordeiro Pedrazzi, Francisco Silveira Guimarães, Alline Cristina Campos, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa · 2024 · Pharmaceuticals
22. Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol
    Jaiyeola Abiola Kajero, Soraya Seedat, JUDE UZOMA OHAERI, Abidemi James Akindele, Oluwagbemiga Olanrewaju Aina · 2020 · The World Journal of Biological Psychiatry
23. Cannabidiol Produces Distinct U-Shaped Dose-Response Effects on Cocaine-Induced Conditioned Place Preference and Associated Recruitment of Prelimbic Neurons in Male Rats
    Hermina Nedelescu, Grant E. Wagner, Genna L. De Ness, Ayla M. Carroll, Tony M. Kerr, Jingjun Wang, Saiwen Zhang, Stephen E. Chang, A. Than, Nora E. Emerson et al. · 2021 · Biological Psychiatry Global Open Science
24. Neuroanatomical substrates involved in cannabinoid modulation of defensive responses
    Fabrício A. Moreira, DC Aguiar, Leonardo B.M. Resstel, Sabrina Francesca de Souza Lisboa, Alline Cristina Campos, Felipe V. Gomes, Francisco Silveira Guimarães · 2011 · Journal of Psychopharmacology
25. Autism and associated disorders: cannabis as a potential therapy
    Mariana Babayeva, Haregewein Assefa, Paramita Basu, Zvi G. Loewy · 2022 · Frontiers in Bioscience-Elite
26. Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry
    Claire Wang, Simon Erridge, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Rahul Guru, Wendy Holden, James Rucker, Michael W. Platt et al. · 2023 · Brain and Behavior
27. Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
    José Diogo S. Souza, Antônio Waldo Zuardi, Francisco Silveira Guimarães, Flávia de Lima Osório, Sônia Regina Loureiro, Alline Cristina Campos, Jaime E. C. Hallak, RAFAEL GUIMARÃES DOS SANTOS, Isabella Lara Machado Silveira, Karina Pereira‐Lima et al. · 2022 · Frontiers in Pharmacology
28. Diazepam effects on aversive memory retrieval and extinction: Role of anxiety levels
    Anderson H.F.F. Leão, Alícia Cabral, Geison Souza Izídio, Alessandra Mussi Ribeiro, Regina H. Silva · 2015 · Pharmacology Biochemistry and Behavior
29. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder
    Jenika Staben, Megan Koch, Keelee Reid, Jessica Muckerheide, Lauren Gilman, Finn McGuinness, Sarina Kiesser, Iain W. H. Oswald, Kevin A. Koby, Thomas J. Martin et al. · 2023 · Frontiers in Neuroscience
30. An Overview of Cannabidiol
    Alexandra Sideris, Lisa Doan · 2023 · Anesthesia & Analgesia
31. Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives
    Gleice Kelli Silva-Cardoso, Christie Ramos Andrade Leite‐Panissi · 2022 · Cannabis and Cannabinoid Research
32. The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
    Kelly A. Sagar, Staci A. Gruber · 2025 · CNS Drugs
33. CB 1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers
    Bruno Mangili de Paula Rodrigues, Norberto Cysne Coimbra · 2022 · Journal of Psychopharmacology
34. Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
    Cathy Davies, Elizabeth Appiah‐Kusi, Robin Paul Wilson, Grace Blest‐Hopley, Matthijs Geert Bossong, Lucia Valmaggia, Michael John Brammer, Jesús Pérez, Paul Allen, Robin M. Murray et al. · 2021 · European Archives of Psychiatry and Clinical Neuroscience
35. Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety
    Danielle K. Fliegel, Sarah D. Lichenstein · 2022 · Psychiatry Research Communications
36. Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
    Barkha J. Yadav-Samudrala, Benjamin Land Gorman, Karenna M. Barmada, Havilah Ravula, Caitlin J. Huguely, E. Diane Wallace, Michelle R. Peace, Justin L. Poklis, Wei Jiang, Sylvia Fitting · 2024 · Frontiers in Neuroscience
37. The design, synthesis and testing of desoxy-CBD: Further evidence for a region of steric interference at the cannabinoid receptor
    Patricia H. Reggio, R.D. Bramblett, H. Yuknavich, Herbert H. Seltzman, Denise N. Fleming, Susanthi R. Fernando, L. A. Stevenson, Roger G. Pertwee · 1995 · Life Sciences
38. Cannabidiol Interferes with Establishment of Δ 9 -Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism
    Marieka V. DeVuono, Olivia La Caprara, Gavin N. Petrie, Cheryl L. Limebeer, Erin M. Rock, Matthew N. Hill, Linda A. Parker · 2020 · Cannabis and Cannabinoid Research
39. Cannabidiol provides viable treatment opportunity for multiple neurological pathologies of autism spectrum disorder
    Bin Gu · 2017 · Global Drugs and Therapeutics
40. The Estrous Cycle Influences the Effects of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibition in the Anxiety-Like Behavior in Rats
    Bruna Wuilleumier Salemme, Ana Maria Raymundi, Jeferson Machado Batista Sohn, Cristina Aparecida Jark Stern · 2023 · Cannabis and Cannabinoid Research
41. Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
    Balapal S. Basavarajappa, Shivakumar Subbanna · 2024 · Biomolecules
42. Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
    María S. García‐Gutiérrez, Daniela Navarro, Amaya Austrich-Olivares, Jorge Manzanares · 2023 · Frontiers in Pharmacology
43. URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels
    Mohaddeseh Ebrahimi-Ghiri, Fatemeh Khakpai, Mohammad‐Reza Zarrindast · 2020 · Journal of Psychopharmacology
44. Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice
    Paloma Molina Hernandes, Matheus Fitipaldi Batistela, Jefferson Manoel Nascimento‐Silva, Alana Tercino Frias, Melina Matthiesen, Alline Cristina Campos, T.A. Lovick, Hélio Zangrossi · 2023 · Behavioural Brain Research
45. The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials
    Carly de Faria Coelho, Rodolfo P. Vieira, Osvaldo Soares de Araújo, Pedro Sardinha Leonardo Lopes-Martins, Layla Saluanne Barbosa dos Santos, Lucas Danilo Dias, Alberto Souza Sá Filho, Patrícia Sardinha Leonardo, Sandro Dutra e Silva, Rodrigo Álvaro Brandão Lopes‐Martins · 2024 · Life
46. Role of Cannabinoid Receptors in Anxiety Disorders
    Aldemar Degroot · 2007 · Springer eBooks
47. Anxiolytic effect of an extract of Salvia miltiorrhiza roots in rats
    Carla Lobina, Giancarlo Colombo, Gian Luigi Gessa, Mauro A.M. Carai, Pietro Allegrini, Paolo Morazzoni, Antonella Riva · 2017 · Journal of the Chinese Medical Association
48. New Ethological and Morphological Perspectives for the Investigation of Panicolytic-Like Effects of Cannabidiol
    Norberto Cysne Coimbra, Joyce Mendes-Gomes, J.A. da Silva, Tayllon dos Anjos‐Garcia, F. Ullah, Rafael Carvalho Almada · 2017 · Elsevier eBooks
49. Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice
    Junhan Liu, Brian W. Scott, Willets McIntyre Burnham · 2021 · Behavioural Pharmacology
50. The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics
    Ahmed, Mashal, Boileau, Isabelle, Le Foll, Bernard, Carvalho, Andre F., Kloiber, Stefan · 2022 · Brazilian Journal of Psychiatry
51. Paternal Cannabis Exposure Prior to Mating, but Not Δ9-Tetrahydrocannabinol, Elicits Deficits in Dopaminergic Synaptic Activity in the Offspring
    Theodore A. Slotkin, Edward D. Levin, Frederic J. Seidler · 2021 · Toxicological Sciences
52. Cannabidiol and 5-HT1A Receptors
    Manoela V. Fogaça, Alline Cristina Campos, Francisco Silveira Guimarães · 2016 · Elsevier eBooks
53. Effect of accumbens nucleus shell lesioning on bitemporal lobe epilepsy in rat model
    Junwu Fu, Yawei Liu, Kaijun Yang, Hao Long, Kewan Wang, Songtao Qi · 2018 · Folia Neuropathologica
54. Distinct Effects of D9-tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
    Paolo Fusar‐Poli · 2009 · European Psychiatry
55. Cannabidiol (CBD) potentiates physiological and behavioral markers of hypothalamic–pituitary–adrenal (HPA) axis responsivity in female and male mice
    Bryan W. Jenkins, Hayley A. Spina, Kate Nicholson, Amy E. M. Newman, Jibran Younis Khokhar · 2025 · Psychopharmacology
56. Serotonin 2A receptors and cannabinoids
    Inés Ibarra‐Lecue, Rebeca Dı́ez-Alarcia, Leyre Urigüen · 2021 · Progress in brain research
57. UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
    Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James Rucker, Mikael Hans Sodergren · 2023 · Neuropsychopharmacology Reports
58. U-shaped curve of psychosis according to cannabis use: New evidence from a snowball sample
    Antía Brañas, María Luisa Barrigón, Nathalia Garrido Torres, Salvador Perona Garcelán, Juan Francisco Rodríguez Testal, Guillermo Lahera, Miguel Ruíz-Veguilla · 2016 · Journal of Psychopharmacology
59. Cannabidiol Modulates the Motivational and Anxiety-Like Effects of 3,4-Methylenedioxypyrovalerone (MDPV) in Mice
    Laia Alegre-Zurano, Raúl López‐Arnau, Miguel Ángel Luján, Jordi Camarasa, Olga Valverde · 2021 · International Journal of Molecular Sciences
60. Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review
    Danielle Hen-Shoval, Aron Weller, Abraham Weizman, Gal Shoval · 2022 · International Journal of Environmental Research and Public Health
61. Therapeutic potential of CBD in Autism Spectrum Disorder
    João Francisco Cordeiro Pedrazzi, Lucas Hassib, Frederico Rogério Ferreira, Jaime E. C. Hallak, Elaine Del-Bel, José Alexandre S. Crippa · 2024 · International review of neurobiology
62. Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice
    João Francisco Cordeiro Pedrazzi, Amanda J. Sales, Rafaela Ponciano, Luciana Garros Ferreira, Frederico Rogério Ferreira, Alline Cristina Campos, Jaime E. C. Hallak, Antônio Waldo Zuardi, E.A. Del Bel, Francisco Silveira Guimarães et al. · 2024 · Pharmacology Biochemistry and Behavior
63. The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial
    Gianna F. Mastrofini, Bridget A. McFadden, Alexa J. Chandler, Blaine S. Lints, Harry P. Cintineo, Nathaniel Rhoades, Caroline S. Vincenty, Sten O. Stray-Gundersen, Abbi D. Lane‐Cordova, Shawn M. Arent · 2024 · Journal of the International Society of Sports Nutrition
64. Effects of cannabidiol on vacuous chewing movements, plasma glucose and oxidative stress indices in rats administered high dose risperidone
    Jaiyeola Abiola Kajero, Soraya Seedat, JUDE UZOMA OHAERI, Abidemi James Akindele, Oluwagbemiga Olanrewaju Aina · 2022 · Scientific Reports
65. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors
    Adriana Jesus Souza, Francisco Silveira Guimarães, Felipe V. Gomes · 2023 · Behavioural Brain Research
66. Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex
    Franciele Franco Scarante, Vinícius Detoni Lopes, Eduardo Junji Fusse, Maria Adrielle Vicente, Gabriel H Dias de Abreu, Viviani Nardini, Carlos A. Sorgi, Pedro Henrique Cassaro Lirio, Feng Guo, Hui‐Chen Lu et al. · 2026 · Neuropharmacology
67. Involvement of Histaminergic System in the Anxiolytic-Like Activities of Morus alba Leaves in Mice
    Seungheon Lee, Dong Hyun Kim, Ji Hye Lee, Eun Seong Ko, Won Bo Oh, Yong Taek Seo, Young Pyo Jang, Jong Hoon Ryu, Ji Wook Jung · 2013 · Biological and Pharmaceutical Bulletin
68. Das endogene Cannabinoidsystem
    Udo Schneider, J. Seifert, Matthias Karst, Jann E. Schlimme, Konrad F. Cimander, Kirsten Müller‐Vahl · 2005 · Der Nervenarzt
69. Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review
    Cassidy Scott, Stefan Hall, Juan Zhou, Christine Lehmann · 2023 · Journal of Clinical Medicine
70. Adaptogenic activity of Cinnamomum camphora, Eucalyptus globulus, Lavandula stœchas and Rosmarinus officinalis essential oil used in North-African folk medicine
    Mahieddine Boumendjel, Abdennour Boucheker, Sandra Feknous, Faïza Taïbi, Naouel Rekioua, Nawel Bouzeraa, Asma Chibi, Nesrine Feknous, Allaeddine Baraoui, Salem N’har et al. · 2021 · Cellular and Molecular Biology
71. Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test
    Ila Marques Porto Linares · 2016
72. Unravelling a potential therapeutic effect of polymeric lipid-core nanoencapsulated cannabidiol on anxiety- and panic-like behaviours elicited by Bothrops jararaca lancehead pit vipers
    Bruno Mangili de Paula Rodrigues, Paloma Molina Hernandes, Rafael Canalle Balvedi, Hígor Ferreira Martins Alves, Karoline Paiva da Silva, Rogério de Campos Bicudo, Marcelo Jung Eberhardt, Fernanda S. Poletto, Karina Paese, Sı́lvia Stanisçuaski Guterres et al. · 2025 · International Journal of Pharmaceutics
73. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
    Luke John Ney · 2025 · International Journal of Molecular Sciences
74. Sex Differences in the Anxiolytic Properties of Common Cannabis Terpenes, Linalool and β-Myrcene, in Mice
    Jasmin Wagner, Ella Gambell, Tucker Gibbons, Thomas J Martin, Joshua S. Kaplan · 2024 · NeuroSci
75. The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration
    Jaiyeola Abiola Kajero, Soraya Seedat, JUDE UZOMA OHAERI, Abidemi James Akindele, Oluwagbemiga Olanrewaju Aina · 2022 · Acta Neuropsychiatrica
76. Cannabidiol in anxiety disorders: Current and future perspectives
    João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, Francisco Silveira Guimarães, José Alexandre S. Crippa · 2024 · International review of neurobiology
77. Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission
    João Francisco Cordeiro Pedrazzi, Danyelle Silva-Amaral, Ana Carolina Issy, Felipe V. Gomes, José A. Crippa, Francisco Silveira Guimarães, Elaine Del Bel · 2024 · Pharmacology Biochemistry and Behavior
78. The Effects of Antioxidant Approved Drugs and Under Investigation Compounds with Potential of Improving Sleep Disorders and their Associated Comorbidities Associated with Oxidative Stress and Inflammation
    Panagiotis Theodosis‐Nobelos, Fani‐Niki Varra, Michail N. Varras, Eleni A. Rekka · 2025 · Mini-Reviews in Medicinal Chemistry
79. Putative effects of cannabidiol in depression and synaptic plasticity
    Sâmia R.L. Joca, Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, Francisco Silveira Guimarães, Gregers Wegener · 2021 · Elsevier eBooks
80. Cannabidiol Treatment Shows Therapeutic Efficacy in a Rodent Model of Social Transfer of Pain in Pair-Housed Male Mice
    Lígia Renata Rodrigues Tavares, Leonardo Abdelnur Petrilli, Daniela Baptista‐de‐Souza, Lucas Canto‐de‐Souza, Cleopatra S. Planeta, Francisco Silveira Guimarães, Ricardo Luiz Nunes‐de‐Souza, Azair Canto‐de‐Souza · 2023 · Cannabis and Cannabinoid Research
81. Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice
    Eduardo Junji Fusse, Franciele Franco Scarante, Maria Adrielle Vicente, Mariana M. Marrubia, Flavia Correa Turcato, Davi S. Scomparin, Melissa A. Ribeiro, Maria José Figueiredo, Tamires Amabile Valim Brigante, Francisco Silveira Guimarães et al. · 2023 · Neuroscience Letters
82. Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models
    Jose J. Rosado‐Franco, Alysha L. Ellison, Cory J. White, AS Price, CF Moore, Richard E Williams, LB Fridman, Elise M. Weerts, Dionna W. Williams · 2024 · Physiological Reports
83. Interactions Between Cannabinoid Signaling and Anxiety: A Comparative Analysis of Intervention Tools and Behavioral Effects
    Manó Aliczki, József Haller · 2015 · Springer eBooks
84. The cannabinoid system: from the point of view of a chemist
    Raphael Mechoulam, Lumir Hanuš · 2004 · Cambridge University Press eBooks
85. Cannabidiol improves L-DOPA-induced dyskinesia and modulates neuroinflammation and the endocannabinoid, endovanilloid and nitrergic systems
    Glauce Crivelaro Nascimento, Gabriela Gonçalves Bálico, Bianca Andretto de Mattos, Maurício dos Santos Pereira, Igor Gustavo Carvalho Oliveira, Maria Eugênia Costa Queiroz, Lilian Carmo Heck, Luiz Carlos Carvalho Navegantes, Francisco Silveira Guimarães, Elaine Del-Bel · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
86. Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis
    Sandip Ghimire, Fabian Kreilaus, Rossana Rosa Porto, Lyndsey L. Anderson, Justin J. Yerbury, Jonathon Carl Arnold, Tim Karl · 2025 · Psychopharmacology
87. Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via in vivo PET Imaging and Behavioral Assessment
    Yu‐Shin Ding, Jiacheng Wang, Vinay Kumar, James A. Ciaccio, Sami Dakhel, Cathy Shunwen Tan, Jonathan Kim, Sabrina Lee, Hilla Katz-Lichtenstein, Zakia Ben Youss et al. · 2022 · International Journal of Innovative Research in Medical Science
88. Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats
    Renaud C. Gom, Pasindu Wickramarachchi, Antis G. George, Savannah H. M. Lightfoot, Dana Newton-Gunderson, Matthew N. Hill, G. Campbell Teskey, Roberto Colangeli · 2024 · Neuropsychopharmacology
89. Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
    Daphnée Brazeau, Amelie A Deshaies, David R. Williamson, Francis Bernard, C. Arbour, A. Pinard, D. Rouleau, L. de Beaumont · 2025 · BMJ Open
90. Cannabidiol Affects MK-801-Induced Changes in the PPI Learned Response of Capuchin Monkeys (Sapajus spp.)
    Patricia Grandizoli Saletti, Rafael Souto Maior, Marília Barros, Hisao Nishijo, Carlos Alberto Bezerra Tomaz · 2017 · Frontiers in Pharmacology
91. The Reversal of Empathy-Induced Hypernociception in Male Mice by Intra-Amygdala Administration of Midazolam and Cannabidiol Depends on 5-HT 3 Receptors
    Lígia Renata Rodrigues Tavares, Daniela Baptista‐de‐Souza, Lucas Canto‐de‐Souza, Cleopatra S. Planeta, Francisco Silveira Guimarães, Ricardo Luiz Nunes‐de‐Souza, Azair Canto‐de‐Souza · 2022 · Cannabis and Cannabinoid Research
92. Cannabinoids and anxiety
    Richard E. Musty · 2005 · Birkhäuser-Verlag eBooks
93. Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review
    Bruno Lemes Marques, Pedro Henrique Cassaro Lirio, Maria Adrielle Vicente, Paula Unzueta‐Larrinaga, Leyre Urigüen, Alline Cristina Campos · 2025 · Pharmaceuticals
94. Historical perspective on the therapeutic potential of cannabidiol
    Francisco Silveira Guimarães · 2024 · International review of neurobiology
95. Cannabidiol inhibits transient receptor potential canonical 4 and modulates excitability of pyramidal neurons in mPFC
    Yujun Han, Shuting Wang, Yu Xiang, Liuliu Chang, Xian Wang, Shimin Ren, Fei Guo, Tianyu Li, Zhiqiang Liu, Yang Li · 2024 · Frontiers in Pharmacology
96. Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model
    Sofia de Almeida Queiroz, Linério Ribeiro de Novais Júnior, Anita Beatriz Pacheco de Carvalho, Tiago Vicente da Silva, Suelen de Souza Ramos, Vicente Meneguzzo, Khiany Mathias, Anita Dal Bó Tiscoski, Natália Piacentini, Mariana Pereira de Souza Goldim et al. · 2025 · Schizophrenia Research
97. Potentiation of endocannabinoid signaling alleviates depressive-like behavior in diabetic mice
    Anuradha Kesharwani, Devidas Lahamge, Shubhankar Kumar Singh, V. Ravichandiran, Vipan Kumar Parihar · 2025 · Pharmacological Research - Reports
98. Well Being
    Jamie Peyton, Katherine Kramer, Brook Quesnell, Stephen Niño Cital · 2021 · Springer eBooks
99. Long-term Effects of Cannabidiol and/or Fentanyl Exposure in Rats Submitted to Neonatal Pain
    Débora Bandeira Rêgo, Michele Longoni Calió, Renato Filev, Luiz E. Mello, Ana Teresa Figueiredo Stochero Leslie · 2023 · Journal of Pain
100. Autism Spectrum Disorder
     Kylie O’Brien, Philip Blair · 2021 · Springer eBooks